The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Headline
Thomas C. “Tom” Dolan, Ph.D., former president and CEO of the American College of Healthcare Executives and a widely respected leader in the healthcare field,…
Chairperson's File
Public
Leadership matters, especially during times of change and transformation in healthcare. That’s why I was pleased to sit down with Steve Walsh, who joined the…
Headline
The California Hospital Association announced Sept. 18 that Bryan Bucklew, president and CEO of Hospital Council – Northern & Central California (a…
Perspective
Public
This weekly column has always been an opportunity to reflect on the issues shaping our field and to contribute to the conversations that move our mission…
Headline
The Association of American Medical Colleges announced Sept. 15 that David J. Skorton, M.D., president and CEO, will retire from his role June 30, 2027.…
Blog
Public
Hospital and health system leaders are navigating workforce shortages, reimbursement pressures, caring for a sicker patient population and rising operational…